ask="4.99"
ask_size="2000"
average_daily_volume="129443"
bid="3.84"
bid_size="100"
book_value="2.54"
change="+0.38"
change_from_200_day_moving_average="-0.48"
change_from_50_day_moving_average="0.34"
change_from_52_week_high="-6.98"
change_From_52_week_low="0.85"
change_in_percent="+8.98%"
close="4.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="24544000"
high="4.69"
high_52_weeks="11.59"
last_trade_date="3/10/2017"
last_trade_price="4.61"
last_trade_size="3299"
last_trade_time="4:00pm"
low="4.22"
low_52_weeks="3.76"
market_capitalization="326.32M"
moving_average_200_day="5.09"
moving_average_50_day="4.27"
name="Adaptimmune Therapeutics plc - "
notes="N/A"
one_year_target_price="14.80"
open="4.29"
pe_ratio="N/A"
peg_ratio="0.30"
percent_change_from_200_day_moving_average="-9.42%"
percent_change_from_50_day_moving_average="+7.93%"
percent_change_from_52_week_high="-60.22%"
percent_change_from_52_week_low="+22.61%"
previous_close="4.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.66"
price_per_sales="31.44"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="4.56"
stock_exchange="NMS"
symbol="ADAP"
volume="517237"
weeks_range_52="3.76 - 11.59"
